Comment: “While clinicians cannot specifically control how the pharmaceutical industry sets prices for medications, we welcome any steps that increase access to agents to prevent cardiovascular events in patients with established…
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices. (New York Times article, October 2, 2018)
When someone suffers a heart attack, the initial focus is often on healing physically. Yet, the emotional journey can be just as impactful, and sometimes even more difficult than expected.…
The Institute for Patient Access released a new Health Plan Coverage Report Card highlighting the rates at which South Carolina insurers deny patients coverage for advanced cholesterol-lowering drugs known as PCSK9 inhibitors.…
Cambia Health Solutions has announced Cheryl Pegus, MD, MPH, as Senior Vice President, Health Care Services and Chief Medical Officer. Dr. Pegus brings over 25 years of clinical practice and operational…
The development of administrative tools for a standardized and centralized process increases access and positively impacts minority and high-risk populations. NEW YORK, NY – August 9, 2018 – The Association…
